Correlates of osteoprotegerin levels in women and men.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Osteoprotegerin (OPG) is a potent antiresorptive molecule that binds the final effector for osteoclastogenesis, receptor activator of NF-kappaB ligand (RANK-L). OPG production is regulated by a number of cytokines and hormones, including sex steroids, but there are few data on age and gender effects on circulating serum OPG levels, as well as possible relationships between OPG levels and bone turnover markers or bone mineral density (BMD). Thus, we measured serum OPG levels in an age-stratified, random sample of men (n = 346 age range, 23-90 years) and women (n = 304; age range 21-93 years) and related them to sex steroid levels, bone turnover markers and BMD. Serum OPG levels increased with age in both men (R = 0.39, p < 0.001) and women (R = 0.18, p < 0.01). Premenopausal women had higher OPG levels than men under age 50 years (171 +/- 6 pg/ml vs 134 +/- 6 pg/ml, respectively, p < 0.001), whereas serum OPG levels were no different in postmenopausal women compared with men = 50 years (195 +/- 7 pg/ml vs 188 +/- 7 pg/ml, respectively, p = 0.179). OPG levels correlated inversely with serum bioavailable testosterone levels in men = 50 years (R = -0.27, p < 0.001), but no associations were present with either estrogen or testosterone levels in the women. In the men, there was a trend for OPG levels to be associated positively with bone resorption markers and inversely with BMD. Collectively, the gender difference in OPG levels suggests that sex steroids may regulate OPG production in vivo, as has been found in vitro. Moreover, OPG production may also rise with increases in bone turnover, probably as a homeostatic mechanism to limit bone loss. Further studies directly testing these hypotheses should provide additional insights into the potential role of OPG in bone loss related to aging and sex steroid deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Residual estrogen levels after the menopause correlate with bone density and fracture risk, yet the relationship of estrogen levels with serum OPG levels in postmenopausal women has been inconsistent across studies, with some supporting a weak relationship (375) and others no relationship (373, 379) or a negative correlation (381).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [373]
In the citing paper
“There is general agreement that OPG levels increase after the menopause (373, 379 -381) and with GnRH agonist therapy (382), both conditions of low estrogen levels.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [373]
In the citing paper
“As with women, serum OPG levels increase with age in men (372,373,376,380,381,391,392).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [373]
In the citing paper
“the evidence is conflicting about an association between markers of bone turnover and circulating OPG because some studies report an association (154,372,375) or an association only among osteoporotic women (384), and others report no association (373,379).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [373]
In the citing paper
“Serum OPG levels have been found to be positively related to BMD (375, 379), negatively related to BMD (374, 383), or unrelated to BMD (372, 373) in postmenopausal women.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [373]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · cited 5×
“Since it is at present unclear what proportion of circulating OPG is monomeric, dimeric or bound to RANK-L [10,24], it seems reasonable to use an assay that detects all forms of circulating OPG.”
BackgroundInfluentialSelf-citationOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · cited 3×
“body and a rabbit polyclonal antibody for detection (Amgen, Thousand Oaks, CA) [3].”
BackgroundMethodSelf-citationYasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228 · cited 5×
“Since it is at present unclear what proportion of circulating OPG is monomeric, dimeric or bound to RANK-L [10,24], it seems reasonable to use an assay that detects all forms of circulating OPG.”
BackgroundInfluentialOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483 · cited 1×
“It is one of the most potent antiresorptive agents known, since transgenic mice overexpressing OPG have profound osteosclerosis and a virtual absence of osteoclasts [3] and, conversely, OPG knockout mice have marked osteopenia and increased numbers of osteoclasts [4,5].”
BackgroundSelf-citationHistory of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443 · cited 1×
“Subjects were recruited from age-stratified random samples of Rochester, Minnesota, men and women selected using the medical records linkage system of the Rochester Epidemiology Project [14].”
MethodHofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,173 · cited 1×
“OPG production by osteoblastic cells is regulated by a number of cytokines and hormones, including sex steroids [6].”
BackgroundSelf-citationHofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.9.7131 · Cited by 692 · cited 2×
“Thus, several studies have found that estrogen (E) increases OPG production [7,8], whereas testosterone (T) tends to inhibit OPG mRNA and protein levels in osteoblastic cells [9].”
BackgroundSelf-citationBrowner, W. S., Lui, L.-Y., & Cummings, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7192 · Cited by 506 · cited 2×
“[11] did not find any association between serum OPG levels and either BMD or fractures in a cohort of postmenopausal women.”
BackgroundYano, K., Tsuda, E., Washida, N., Kobayashi, F., Goto, M., Harada, A., Ikeda, K., Higashio, K., & Yamada, Y. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.4.518 · Cited by 363 · cited 9×
“[10] did note a positive association between serum OPG levels and markers of bone turnover and a negative association between OPG and BMD in postmenopausal women, although they did not report comparable data in men.”
BackgroundResultInfluentialDelmas, P. D., Stenner, D., Wahner, H. W., Mann, K. G., & Riggs, B. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110882 · Cited by 353 · cited 1×
“Bone formation was assessed by serum osteocalcin, measured by RIA (interassay CV 56%) [18] as well as by serum bone-specific alkaline phosphatase (BSAP) measured by enzyme-linked immunosorbent assay [18] (ELISA; interassay CV 511%).”
MethodSelf-citation
Cited by
Items 101–200 of 204
Osteoprotegerin as a biomarker of geriatric frailty syndrome
Valentini, A., Cianfarani, M. A., Tarantino, U., Daniele, N. D., & Bertoli, A. (2019) · Aging · doi:10.18632/aging.102083 · Cited by 19
“Moreover, OPG is a protein involved in different physiopathologic conditions including bone, vascular, immune and tumor disease [24] and several studies found a positive linear correlation between OPG and age [25, 26, 27].”
BackgroundShaarawy, M., Fathy, S. A., Mehany, N. L., & Hindy, O. W. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.306 · Cited by 20
Savarino, L., Avnet, S., Greco, M., Giunti, A., & Baldini, N. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21082 · Cited by 18
Schneider, R., Steinmetz, C., Karakas, E., Bartsch, D. K., & Schlosser, K. (2018) · European Surgical Research · doi:10.1159/000486172 · Cited by 18
Lee, J. S., Ryu, C. H., Moon, N. H., Kim, S., Park, S. Y., & Suh, K. T. (2008) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-008-0632-8 · Cited by 18
“The most common explanation for the age-related OPG increase is that it might be an attempt to compensate for the decrease in bone mineral density, which occurs with aging as well as in other diseases with high bone turnover [12, 28].”
BackgroundOsteoclast: Origin and Differentiation
Rubin, J. E., & Greenfield, E. M. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_1 · Cited by 34
“These and other studies suggest that OPG is modified with respect to the bone remodeling rate [78].”
BackgroundBone Loss Among Women Living With HIV
Weitzmann, M. N., Ofotokun, I., Titanji, K., Sharma, A., & Yin, M. T. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0336-6 · Cited by 18
Amer, O. E., Wani, K., Ansari, M. G. A., Alnaami, A. M., Aljohani, N., Abdi, S., Hussain, S. D., Al‐Daghri, N. M., & Alokail, M. S. (2022) · Medicina · doi:10.3390/medicina58080976 · Cited by 19
“As a result, measuring the RANKL/OPG ratio may reflect levels from both non-skeletal and skeletal sources [15].”
Simonini, G., Masi, L., Giani, T., Piscitelli, E., Cimaz, R., Vierucci, S., Brandi, M. L., & Falcini, F. (2005) · PubMed · Cited by 19
Özkalaycı, F., Gülmez, Ö., Ugur‐Altun, B., Pandi-Perumal, S. R., & Altun, A. (2018) · Balkan Medical Journal · doi:10.4274/balkanmedj.2018.0579 · Cited by 21
“(30) demonstrated that OPG levels were positively correlated with bone turnover markers in the male gender.”
BackgroundResultInfluentialQuantitative genetics of circulating molecules associated with bone metabolism: a review.
Livshits, G. (2006) · PubMed · Cited by 19
Valleala, H., Mandelin, J. M., Laasonen, L., Koivula, M.-K., Risteli, J., & Konttinen, Y. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480527 · Cited by 19
“Although these findings were not confirmed by Szulc et al. (8) in a cohort of 252 healthy men, a generally accepted hypothesis is that OPG levels may increase with increases in bone turnover, possibly as a compensatory mechanism ( 14 ).”
ResultKim, J. G., Kim, J. H., Lee, D. O., Kim, H., Kim, J. Y., Suh, C. S., Kim, S. H., & Choi, Y. M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318133a153 · Cited by 18
Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus
Kiani, A. N., Aukrust, P., Ueland, T., Hollan, I., Barr, E., Magder, L. S., & Petri, M. (2016) · Lupus · doi:10.1177/0961203316682101 · Cited by 16
Use of Bone Turnover Markers in Osteoporosis
Lenora, J., Ivaska, K. K., & Gerdhem, P. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9042-x · Cited by 20
“OPG levels increase with age, higher levels have been found in postmenopausal and elderly women, probably as a homeostatic response to limit the bone loss [104].”
BackgroundReyes‐García, R., Muñoz‐Torres, M., García, D. F., Mezquita‐Raya, P., Salcedo, J. A. G., & Luna, J. D. D. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ac0cc1 · Cited by 17
Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?
Moreno, P. R., García, R. R., García‐Martin, A., Varsavsky, M., Garcia-Salcedo, J. A., & Muñoz‐Torres, M. (2013) · PubMed · doi:10.3275/8285 · Cited by 15
Starlinger, J., Kaiser, G., Thomas, A., & Sarahrudi, K. (2019) · Bone and Joint Research · doi:10.1302/2046-3758.87.bjr-2018-0116.r3 · Cited by 14
Malliga, D.-E., Wagner, D., & Fahrleitner‐Pammer, A. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0022-7 · Cited by 14
“The authors conclude that steroid hormones may influence OPG expression [ 60 ].”
BackgroundCan Biomarkers and PET Imaging Predict Abdominal Aortic Aneurysm Growth Rate?
Brüls, S., Musumeci, L., Courtois, A., Hustinx, R., Sakalihasan, S., Namur, G., Defraigne, J.-O., & Sakalihasan, N. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082448 · Cited by 13
“Khosla et al. showed that circulating OPG was higher in women (mainly pre-menopausal) than in men [30].”
BackgroundRANKL elevation activates the NIK/NF-κB pathway, inducing obesity in ovariectomized mice
Mori, K., Mizokami, A., Sano, T., Mukai, S., Hiura, F., Ayukawa, Y., Koyano, K., Kanematsu, T., & Jimi, E. (2022) · Journal of Endocrinology · doi:10.1530/joe-21-0424 · Cited by 14
Serum osteoprotegerin levels are related to height loss: The Tromsø Study
Jørgensen, L., Hansen, J., Brox, J. H., Mathiesen, E. B., Vik, A., & Jacobsen, B. K. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9555-8 · Cited by 15
“Several cross-sectional studies have examined the relationship between BMD and OPG, finding no association [19, 26–36], a positive [37] and an inverse relationship between the two [18, 38–40].”
Wu, X., Wu, X., Xie, H., Zhang, H., Luo, X., Liu, S., Peng, Y., Dai, R.-C., & Liao, E.-Y. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.11.024 · Cited by 13
Ricci, P., Tauchmanovà, L., Risitano, A. M., Carella, C., Mazziotti, G., Lombardi, G., Colao, A., Rotoli, B., & Selleri, C. (2006) · Transplantation · doi:10.1097/01.tp.0000244588.42519.72 · Cited by 14
“Paradoxically, serum OPG (sOPG) was found increased in postmenopausal osteoporosis and in several other conditions characterized by bone loss such as Paget disease, lytic bone metastases, or rheumatoid arthritis (14,15); this increase was interpreted as a compensatory mechanism consequent to bone demineralization.”
BackgroundKwok, S.-K., Shin, Y., Kim, H., Kim, H. S., Kim, J., Yoo, S., Choi, J., Kim, W., & Cs, C. (2009) · Lupus · doi:10.1177/0961203308094819 · Cited by 12
Sandner‐Kiesling, A. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/499 · Cited by 12
Piatek, S., Adolf, D., Wex, T., Halangk, W., Klose, S., Westphal, S., Amthauer, H., & Winckler, S. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.01.005 · Cited by 12
Osteoprotegerin and C-telopeptide of type I collagen in Polish healthy children and adolescents.
Gajewska, J., Ambroszkiewicz, J., & Laskowska–Klita, T. (2006) · PubMed · Cited by 17
Tamaki, J., Iki, M., Morita, A., Ikeda, Y., Sato, Y., Kajita, E., Kagamimori, S., Kagawa, Y., & Yoneshima, H. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0965-3 · Cited by 12
“However, a number of studies did not find significant associations between OPG values and BMD [18, 19].”
BackgroundThe Impact of Sex Hormone Changes on Bone Mineral Deficit in Chronic Renal Failure
Doumouchtsis, K., Perrea, D. N., & Doumouchtsis, S. K. (2009) · Endocrine Research · doi:10.1080/07435800903127598 · Cited by 13
“Other research revealed that women have slightly higher levels of OPG than men (33) and that serum concentration of OPG in women positively correlates with E2 serum concentrations (34).”
BackgroundOPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis
Wittersheim, E., Mesquita, M. D. C. F., Demulder, A., Guns, M., Louis, O., Mélot, C., Dratwa, M., & Bergmann, P. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.01.020 · Cited by 14
Menzel, J., di Giuseppe, R., Biemann, R., Aleksandrova, K., Kuxhaus, O., Wittenbecher, C., Fritsche, A., Schulze, M. B., Isermann, B., Boeing, H., et al. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0544-3 · Cited by 12
“Nonetheless, experimental studies indicate an OPG-dependent bone remodeling mechanism, whereas human studies have provided controversial results regarding the relationship of OPG on bone remodeling marker and BMD [39–42].”
ResultRen, Y., Zhao, T., Zhang, K., Zhu, Z., Li, L., Li, Y., Jiang, S., Jiao, N., & Yang, W. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1196334 · Cited by 11
“(40) reported a compensatory increase in OPG inhibition of abnormal bone resorption in postnatal rats due to lactation, which disturbed Ca and P metabolism in vivo.”
BackgroundSecchiero, P., Corallini, F., Castellino, G., Bortoluzzi, A., Caruso, L., Bugatti, S., Bosco, R., Montecucco, C., & Trotta, F. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091363 · Cited by 11
Osteoprotegerin is associated with hip fracture incidence: the Tromso Study
Jørgensen, L., Hansen, J., Ahmed, L. A., Bjørnerem, Å., Emaus, N., Joakimsen, R. M., Mathiesen, E. B., Störmer, J., Vik, A., & Jacobsen, B. K. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys063 · Cited by 12
Ketlogetswe, K. S., McKibben, R. A., Jacobson, L. P., Li, X., Dobs, A. S., Budoff, M. J., Witt, M. D., Palella, F. J., Kingsley, L., Margolick, J. B., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000725 · Cited by 11
“Because it was limited to men, the results may not be generalizable to women, in whom the OPG/RANKL may be regulated differently.(38) In addition, the measured serum OPG and RANKL concentrations may not be reflective of levels expressed locally in the vasculature.”
ResultKurz, K., Herold, M., Russe, E., Klotz, W., Weiß, G., & Fuchs, D. (2015) · Disease Markers · doi:10.1155/2015/276969 · Cited by 12
“Unfortunately, we could not determine OPG and sRANKL levels in healthy individuals; however, earlier studies could show that aging goes along with increasing OPG levels [43, 44].”
ResultSerum Levels of Bone Turnover Markers following Total Joint Arthroplasty
Kenanidis, E. I., Potoupnis, M. E., Papavasilioul, K. A., Sayegh, F. E., Petsatodis, G. E., & Kapetanos, G. A. (2010) · Journal of orthopaedic surgery · doi:10.1177/230949901001800307 · Cited by 10
Éva, K.-J., Pethő, Z., Pap, Z. V., Kalina, E., Földesi, R., Balogh, Á. L., Antal‐Szalmás, P., & Bhattoa, H. P. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0684-1 · Cited by 12
“Our finding of negative correlation between testosterone and OPG supports two and disagrees with another 2 previous studies [5, 7, 8, 14].”
ResultSzulc, P., Chapurlat, R. D., & Hofbauer, L. C. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3213 · Cited by 11
Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients
Naumnik, B., Klejna, K., Koc‐Żórawska, E., & Myśliwiec, M. (2013) · Advances in Medical Sciences · doi:10.2478/ams-2013-0026 · Cited by 10
Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women
Xie, G., Lei, D.-D., He, H., Gong, J., Chen, C., Chen, P., Zhang, H., Luo, X., Liao, E.-Y., & Wu, X. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.04.019 · Cited by 12
Steagall, W. K., Pacheco–Rodriguez, G., Glasgow, C. G., Ikeda, Y., Lin, J., Zheng, G., & Moss, J. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.024 · Cited by 10
Are skeletally mature female rats a suitable model to study osteoporosis?
Netto, C. C., Vieira, V. C. C., Marinheiro, L. P. F., Agellon, S., Weiler, H. A., & Maróstica, M. R. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000400007 · Cited by 9
“(24), who measured serum OPG levels in an age-stratified, random sample of men (n = 346 age range, 2390 years) and women (n = 304; age range 21-93 years), and showed that serum OPG levels increased with age in both men and women (171 ± 6 pg/mL; 134 ± 6 pg/mL, respectively).”
BackgroundWu, W.-T., Lee, R.-P., Wang, C., Fang, T., Lin, N.-T., Chen, I., & Hsu, B. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1577 · Cited by 9
“correlation with bone mineral density (BMD) in healthy persons.(11) Hemodialysis (HD) patients with low BMD of the femoral neck demonstrate higher OPG levels than patients with normal BMD.”
Pepene, C. E., Crişan, N., & Coman, I. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i4.15365 · Cited by 10
“Nonetheless, results from previous clinical studies, which examined the relationships between BMD, as assessed by dual X-ray absorptiometry (DXA), and serum OPG/RANKL levels in various male populations were conicting and rather inconclusive [1,16-18,26].”
ResultRelationship between Lipid Profile and Bone Turnover in Pre and Postmenopausal Women
Saghafi, H., Hossein‐Nezhad, A., Rahmani, M., & Larijani, B. A. (2008) · Cited by 9
Eleftheriades, M. I., Lambrinoudaki, I. V., Christodoulakos, G., Gregoriou, O., Economou, E. V., Kouskouni, E. E., Antoniou, A. G., Perrea, D. N., Dontas, I. A., Raptou, P. D., et al. (2005) · Contraception · doi:10.1016/j.contraception.2004.10.009 · Cited by 11
“A second increase in OPG levels is observed after 45 years, and circulating OPG remains elevated until senescence [59–61].”
BackgroundLiu, P. Y., Hoey, K. A., Mielke, K. L., Veldhuis, J. D., & Khosla, S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1583 · Cited by 9
Self-citationSarink, D., Yang, J., Johnson, T., Chang-Claude, J. C., Overvad, K., Olsen, A., Tjønneland, A. M., Fournier, A., Mancini, F. R., Kvaskoff, M., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0241 · Cited by 9
“OPG concentrations are known to increase with age [12, 13, 35], which was confirmed in our 262”
BackgroundGunsser, J., Hermann, R., Roth, A. J., & Lupp, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0227133 · Cited by 8
“Previous studies have likewise reported correlations between OPG and TP1NP [64], between AP and TRAP5b [74], and between osteocalcin and TRAP5b [74].”
BackgroundInfluentialKaraarslan, S., Büyükyazı, G., Taneli, F., Ulman, C., Tıkız, C., Gümüşer, G., & Şahan, P. (2010) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2008-8721 · Cited by 10
Norian, J. M., Zeitlian, G., Adel, G., Freeman, R. G., Santoro, N. F., & Pal, L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.089 · Cited by 8
The Potential of Indole Alkaloids in Bone Health and Osteoporosis Management
Caruso, A., Caira, V., El‐Kashef, H., & Saturnino, C. (2024) · Applied Sciences · doi:10.3390/app14188124 · Cited by 7
Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model
Weitzmann, M. N., Weiss, D., Vikulina, T., Roser‐Page, S., Yu, K., McGee‐Lawrence, M. E., Tu, C., Chang, W., & Ofotokun, I. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab631 · Cited by 7
Kenanidis, E. I., Potoupnis, M. E., Papavasiliou, K., Pellios, S., Sayegh, F. E., Petsatodis, G. E., Karatzas, N. D., & Kapetanos, G. A. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.09.029 · Cited by 7
Rahnama, M., Jastrzębska-Jamrogiewicz, I., Jamrogiewicz, R., Nogalski, A., & Jagielak, M. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0149 · Cited by 7
Akhtar, S. M. M., Ali, A., Fareed, A., & Hasan, J. (2024) · Health Science Reports · doi:10.1002/hsr2.2253 · Cited by 6
“18 Further, conducting an in ‐ depth analysis to discern the relationship between OPG levels and ventricular function holds promise, given the frequent alterations in ventricular dynamics observed in CVDs, presenting a pivotal prognostic indicator.”
BackgroundSerum Osteoprotegerin and Sex Steroid Levels in Patients With Prostate Cancer
Varsavsky, M., Reyes‐García, R., Perez, M. D., Ramírez, A. R. G., Mijan, J. L., & Muñoz‐Torres, M. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.014696 · Cited by 7
Decreased serum osteoprotegerin levels in patients with cardiac syndrome X
Altun, A., Ugur-Altun, B., & Tatlı, E. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03346278 · Cited by 8
Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly
Halupczok-Żyła, J., Jawiarczyk-Przybyłowska, A., & Bolanowski, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1472680 · Cited by 6
Osteoprotegerin in T urner syndrome – relationship to aortic diameter
Trolle, C., Mortensen, K. H., Bjerre, M., HOUGAARD, D. M., Cohen, A. S., Andersen, N. H., & Gravholt, C. H. (2014) · Clinical Endocrinology · doi:10.1111/cen.12522 · Cited by 5
Park, S. S., Uzelac, A., & Kotsopoulos, J. (2022) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-022-00223-3 · Cited by 6
(2003) · doi:10.1007/978-1-4757-4561-0 · Cited by 5
Ayina, C. N. A., Boudou, P., Fidaa, I., Balti, E. V., Sobngwi, E., Ngoa, L. S. E., & Gautier, J. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.05.006 · Cited by 4
Laboratory Assessment of Postmenopausal Osteoporosis
Garnero, P., & Delmas, P. D. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0388 · Cited by 4
Role of gender & age in chronic periodontal disease
Jain, A. R., & Bhavsar, N. V. (2021) · IP International Journal of Periodontology and Implantology · doi:10.18231/j.ijpi.2021.020 · Cited by 3
Endocrinology of Bone and Growth Disorders
Farquharson, C., Stephen, L. A., & Wong, S. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00086-4 · Cited by 3
Chudek, J. T., Pośpiech, M., Chudek, A., Holecki, M. T., & Puzianowska‐Kuźnicka, M. (2025) · Diagnostics · doi:10.3390/diagnostics15020219 · Cited by 2
“Summarizing the above-mentioned data, it seems reasonable to state that alterations in serum OPG levels mostly reflect ongoing vascular disease, with some effects on bone metabolism [81,91–95].”
Abbood, M. J., & Abdullah, A. H. (2026) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2026.100681 · Cited by 3
“16 From a therapeutic perspective, osteoporosis management includes antiresorptive agents such as bisphosphonates and denosumab; anabolic therapies such as teriparatide/abaloparatide and romosozumab for very high fracture risk; and supportive strategies, including adequate calcium/vitamin D intake,…”
Bone Biology: Bone Structure and Remodeling
Raisz, L. G. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50003-1 · Cited by 3
IMMUNOPATHOGENETIC MECHANISMS OF PERIODONTAL DISEASE AND POSTMENOPAUSAL OSTEOPOROSIS
Đorđević, N. S., Medarov, M., Kostić, M. S., Petrović, M. S., Cekić, S., & Ajduković, Z. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
dos Santos-Macedo, F., Gregório, B. M., Paes-de-Almeida, E. C., Mendonça, L. D. S., AZEVEDO, R. D. S., & Fernandes‐Santos, C. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152517 · Cited by 2
Die Rolle von RANK-Ligand und Osteoprotegerin bei Osteoporose
Hofbauer, L. C. (2004) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 4
Mokhber, A., Hall, E., Uzelac, A., Salmena, L., Cheung, A. M., Lubiński, J., Narod, S. A., & Kotsopoulos, J. (2024) · Bone Reports · doi:10.1016/j.bonr.2024.101802 · Cited by 1
“Due to the pivotal role of this pathway in bone remodeling, its' dysregulation plays an important step in the development of osteoporosis as well as cancer-induced bone disease (Khosla et al., 2002; Piatek et al., 2013; Whyte and Mumm, 2004).”
BackgroundInfluentialOh, K. W., Yun, E. J., Rhee, E., Lee, W., Baek, K. H., Kang, M. I., Park, C., Ihm, S. H., Choi, M. G., Yoo, H. J., et al. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.3.204 · Cited by 2
Ji, B., Yang, Q. Z., Genever, P. G., Patton, R. J., & Fagan, M. J. (2014) · Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine · doi:10.1177/0954411914554633 · Cited by 1
Fisiología del hueso y marcadores bioquímicos del recambio óseo
Canelas, A. C., Cenarruzabeitia, N. V., & Corrales, E. P. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00002-2 · Cited by 2
Tae, H. J., Baek, K., Oh, E.-S., Oh, K. W., Lee, W., Kim, H.-S., Han, J.-H., Cha, B. Y., Lee, K. W., Son, H., et al. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.1.40 · Cited by 1
“인체에서의 연구는 부족한 상태이며, 최근 정상 성인 에서 혈중 OPG 농도를 측정하여 골밀도 및 골대사와 의 상관성에 대해 보고된 바 있으나[25,26] 이식 직후 골소실이 뚜렷이 발생하는 조혈모세포이식 후의 RANKL와 OPG 변화 및 그 임상적 의의에 대해서는 알 려진 바가 없다.”
Park, S. Y., Suh, K. T., Ryu, C. H., Woo, S. H., Lee, J. S., & Kim, S.-G. (2008) · Journal of the Korean Fracture Society · doi:10.12671/jkfs.2008.21.2.145 · Cited by 1
Liu, J., Zhao, H., Ning, G., Zhao, Y., Chen, Y., Zh, L., Sun, L., Xu, Y., & Chen, J. L. (2005) · Cited by 1
Molekulare Mechanismen altersspezifischer Veränderungen des Kalzium- und Knochenstoffwechsels
Jakob, F. J., & Schütze, N. (2004) · Springer eBooks · doi:10.1007/978-3-642-18741-4_13 · Cited by 1
Bone turnover markers and prediction of bone loss in elderly women
Lenora, J. (2009) · Lund University Publications (Lund University) · Cited by 2
Bolon, B. N., Shalhoub, V., Kostenuik, P. J., Zack, D. J., & Feige, U. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7883-8_10
Bedeutung von RANK-Ligand und Osteoprotegerin für den Knochenstoffwechsel
Hofbauer, L. C., & Schoppet, M. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_21 · Cited by 1
Ashley, D. T. (2010) · Dublin City University Open Access Institutional Repository (Dublin City University)
Calcitropic Hormones and Systemic Factors of Vascular Calcification
Oh, K. W., & Kang, M. I. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.6.561
García, D. F. (2011) · Institutional Repository of the University of Granada (University of Granada) · Cited by 1
Ćelić, T. (2012) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.1000125
“The positive correlation between age and OPG was already noticed in healthy population and end stage renal disease [37,38].”
BackgroundValleala, H. (2005) · Helda - University of Helsinki Institutional Repository
Gnerre, P., & Nardi, R. (2016) · Italian Journal of Medicine · doi:10.4081/itjm.q.2016.4
Raheem (2012) · International Journal of Clinical Pediatrics · doi:10.4021/ijcp25w
“Other factors that may affect OPG serum levels like female sex, age changes and systolic hypertension [39-41] were excluded in our study by selection of noromotensive prepubertal boys with comparable age and sex matched healthy controls.”
BackgroundPignolo, R. J., & Kaplan, F. S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7216-2872-1.50043-1
Shahbazi, M. (2021) · Research in Molecular Medicine · doi:10.32598/rmm.9.2.6
“using high-intensity exercise on bone-related cytokines in young men [56] and Kish et al.”
BackgroundMethodPark, S. S., Zaman, T., Kim, S. J., Brooks, J. D., Wong, A. K. O., Lubiński, J., Narod, S. A., Salmena, L., & Kotsopoulos, J. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0577
Pancheva, R., Dyankova, Y., Rasheva, N., Koleva, K., Iotova, V., Dzhogova, M., Fiore, M., & Georgieva, M. (2025) · Nutrients · doi:10.3390/nu17142295
Chausheva, G. M., Shefket, S., Tsochev, Κ., Chalakova, T., Bocheva, Y., Yotov, Y. T., & Iotova, V. (2025) · Bulgarian Cardiology · doi:10.3897/bgcardio.31.e169297
Ng, P. K. L., & Clark, P. F. (2008) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.184462
Endothelial RANK signaling triggers bone marrow inflammaging through IL-1β expressionPreprint
Kobayashi, Y., Iwamoto, R., Takahashi, T., Ishida, M., He, Z., Murakami, K., Hara, T., Ganbaatar, B., Yamagami, H., Endo, I., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10899322/v1
Metadata
- Authors
- Khosla, S., Arrighi, H. M., Melton, III, Atkinson, E. J., O'Fallon, W. M., Dunstan, C., & Riggs, B. L.
- Affiliations
- Mayo Clinic (US)
- Amgen (United States) (US)
- Venue
- Osteoporosis International
- Published
- 2002-05-01
- Volume
- 13
- Issue
- 5
- Pages
- 394-399
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2034959911
- Cited by
- 205
- References
- 19
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 6 · 2013: 9 · 2012: 10
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 27065, R01AR027065)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- osteoprotegerin, sex steroids, testosterone, estrogen, bone turnover markers, bone mineral density, bone resorption, menopause, aging, sex differences, RANK ligand, bone loss, bone homeostasis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Enzyme-Linked Immunosorbent Assay, Estradiol, Female, Glycoproteins, Humans, Male, Middle Aged, Sex Characteristics, Testosterone, Bone Remodeling, Premenopause, Postmenopause, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Statistics, Nonparametric, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.